Evidence 1
Activity
Activity
10% Killing
Toxicity
128 µM
Cytotoxic
10% Killing | 128 | µM | target cell: Human embryonic kidney HEK293 cells
Target
Human embryonic kidney HEK293 cells
Source & Reference
NA
DBAASP
De Novo Designed Hexadecapeptides Synergize Glycopeptide Antibiotics Vancomycin and Teicoplanin against Pathogenic Klebsiella pneumoniae via Disruption of Cell Permeability and Potential | ACS Appl Bio Mater | 2020